Literature DB >> 12671769

[Tissue engineering in urology. Basic principles and application].

G Bartsch1, A Atala.   

Abstract

Tissue engineering is a rather new field of science. Despite this fact, some experimental investigations have already been applied in clinical studies. Compared to other medical fields, tissue engineering in urology is well established. Tissue-engineered bulking agents and tissue-engineered bladder augments are being investigated in clinical trials. Even though the knowledge gained in recent years is promising, the results of cellular therapies need to be critically judged before being finally applied in patients. Genetic engineering and stem cell research (adult undifferentiated cells) have had major impact on the field of tissue engineering over the past 2 years. By using the technology of genetic engineering, biochemical and functional qualities of tissues may be modified. Adult stem cells may help to substitute lost tissue in an autologous fashion by isolating undifferentiated cells from the body and by differentiating them into a desired cell type. These cells may be used to form native functional tissue to replace a diseased organ or organ part.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671769     DOI: 10.1007/s00120-003-0304-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  56 in total

1.  Tissue engineering of a bioartificial kidney.

Authors:  D A Cieslinski; H David Humes
Journal:  Biotechnol Bioeng       Date:  1994-03-25       Impact factor: 4.530

Review 2.  The angiopoietins: Yin and Yang in angiogenesis.

Authors:  S Davis; G D Yancopoulos
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 3.  Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.

Authors:  M S Pepper
Journal:  Cytokine Growth Factor Rev       Date:  1997-03       Impact factor: 7.638

4.  De novo reconstitution of a functional mammalian urinary bladder by tissue engineering.

Authors:  F Oberpenning; J Meng; J J Yoo; A Atala
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

5.  Homologous bladder augmentation in dog with the bladder acellular matrix graft.

Authors:  M Probst; H J Piechota; R Dahiya; E A Tanagho
Journal:  BJU Int       Date:  2000-02       Impact factor: 5.588

6.  Bladder augmentation using allogenic bladder submucosa seeded with cells.

Authors:  J J Yoo; J Meng; F Oberpenning; A Atala
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

7.  Isolation of multipotent adult stem cells from the dermis of mammalian skin.

Authors:  J G Toma; M Akhavan; K J Fernandes; F Barnabé-Heider; A Sadikot; D R Kaplan; F D Miller
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

8.  Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro.

Authors:  A Atala; J P Vacanti; C A Peters; J Mandell; A B Retik; M R Freeman
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

9.  Selective propagation of retinal pericytes in mixed microvascular cell cultures using L-leucine-methyl ester.

Authors:  C S Lee; W F Patton; N Chung-Welch; E T Chiang; K H Spofford; D Shepro
Journal:  Biotechniques       Date:  1998-09       Impact factor: 1.993

10.  Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children.

Authors:  P Frey; N Lutz; P Jenny; B Herzog
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

View more
  1 in total

1.  [Biological vascularized matrix (BioVaM): a new method for solving the perfusion problems in tissue engineering].

Authors:  D Schultheiss; A I Gabouev; P M Kaufmann; N Schlote; H Mertsching; A Haverich; C G Stief; U Jonas
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.